Spondyloarthritis in 2012: Advances in pathogenesis through animal models and imaging.
Advances in 2012 have helped to solve several established mysteries in spondyloarthritis (SpA) - why T-cell-directed therapies have not delivered the expected efficacy and how the IL-23-IL-17 cytokine axis is linked to the specific pathology of SpA. The opportunity to influence disease progression at inflammatory lesions using anti-TNF agents may be fleeting.